A Unique Case of Myositis

A Unique Case of Myositis

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a rare systemic small-vessel disease, with heterogeneous clinical manifestations. While arthralgia and myalgia are common in the disease course, frank myositis is exceedingly rare. Immune-mediated necrotizing myopathy (IMNM)...

Full description

Bibliographic Details
Main Authors:	Noa Hurvitz, Ariel Kenig, Asa Kessler, Narmine Elkhateeb, Yossef Lerner, Michal Zamir, Fadi Kharouf
Format:	Article
Language:	English
Published:	Rambam Health Care Campus 2022-10-01
Series:	Rambam Maimonides Medical Journal
Subjects:	anca-associated vasculitis idiopathic inflammatory myopathy myalgia myositis rituximab
Online Access:	https://www.rmmj.org.il/issues/55/1516/manuscript

Similar Items

MYOSITIS ASSOCIATED WITH MALIGNANT TUMORS
by: O. A. Antelava, et al.
Published: (2016-07-01)

Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis
by: Marcela Gran Pina Cruellas, et al.
Published: (2013-07-01)

Update on Malignancy in Myositis—Well-Established Association with Unmet Needs
by: Aleksandra H. Opinc, et al.
Published: (2022-01-01)

Benign acute childhood myositis – a case report
by: Dorota Szałowska-Woźniak
Published: (2017-09-01)

Investigating idiopathic inflammatory myopathy; initial cross speciality experience with use of the extended myositis antibody panel
by: Antoinette O'Connor, et al.
Published: (2017-05-01)

The Impact of Dysphagia in Myositis: A Systematic Review and Meta-Analysis
by: Bendix Labeit, et al.
Published: (2020-07-01)

A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol
by: Mark E. McClure, et al.
Published: (2023-03-01)

Coexistence of Multiple Myositis-Specific Antibodies in Patients with Idiopathic Inflammatory Myopathies
by: Hung-Ling Huang, et al.
Published: (2022-11-01)

Paraspinal myositis in a patient with COVID-19 infection: a case report
by: Watsachon Pangkanon, et al.
Published: (2023-08-01)

Myositis and myopathy of sarcoidosis: A case report
by: Tucker v R. Burr, MD, et al.
Published: (2021-03-01)

Ultra-efficient sequencing of T Cell receptor repertoires reveals shared responses in muscle from patients with Myositis
by: Janelle M. Montagne, et al.
Published: (2020-09-01)

Myositis Detection From Muscle Ultrasound Images Using a Proposed YOLO-CSE Model
by: Alaa Hussein Ahmed, et al.
Published: (2023-01-01)

Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study
by: Gianluca Sambataro, et al.
Published: (2023-02-01)

Hypophysitis Secondary to Small Vessel ANCA Vasculitis Treated With Rituximab
by: Nankee K. Kumar, AB, et al.
Published: (2024-03-01)

Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives
by: Elena Treppo, et al.
Published: (2021-08-01)

Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly
by: Roberta Fenoglio, et al.
Published: (2020-10-01)

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
by: Frank B. Cortazar, et al.
Published: (2018-03-01)

Acute Proximal Myopathy in a Young Male—A Case of Infectious Myositis
by: Rashmi Dhital, et al.
Published: (2019-01-01)

Early addition of rituximab in the management of myositis associated with systemic lupus erythematosus
by: Mervat E Behiry, et al.
Published: (2019-01-01)

The Genetics of Autoimmune Myositis
by: Janine A. Lamb
Published: (2022-05-01)

Myositis-associated antibodies predict the severity of lung involvement in adult patients with inflammatory myositis − a cohort study of 70 adult patients with myositis in a single center
by: Josefin Marklund, et al.
Published: (2024-03-01)

What should we expect when two myositis-specific antibodies coexist in a patient
by: Yiming Zheng, et al.
Published: (2023-10-01)

Adding low dose cyclophosphamide to rituximab for remission-induction may prolong relapse-free survival in patients with ANCA vasculitis: A retrospective study
by: Renée Ysermans, et al.
Published: (2023-01-01)

Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation
by: Yusuke Miyazaki, et al.
Published: (2020-06-01)

Otologic manifestations in the setting of seronegative small vessel vasculitis: A case report
by: Kathleen Gillmore, et al.
Published: (2023-06-01)

Myalgia, Obtundity and Fever in a Patient with a Prosthesis
by: Valeria Di Stefano, et al.
Published: (2019-02-01)

Inclusion body myositis: Update on the diagnostic and therapeutic landscape
by: Elie Naddaf
Published: (2022-09-01)

Phenotypical statin‐associated immune‐mediated necrotizing myositis with histological features of inclusion body myositis
by: Nicole Daver, et al.
Published: (2023-03-01)

Inclusion Body Myositis Treated with Alemtuzumab
by: Juliana Sá, et al.
Published: (2019-12-01)

Myositis associated with localized lipodystrophy: an unrecognized condition?
by: Gdynia H-J, et al.
Published: (2009-05-01)

A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies
by: Gianluca Sambataro, et al.
Published: (2022-05-01)

Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy
by: Dario Roccatello, et al.
Published: (2022-03-01)

Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients
by: Laura S. van Dam, et al.
Published: (2020-12-01)

Idiopathic lateral rectus myositis in preteens: A case report
by: Sepideh Porhajihosseini, MD, et al.
Published: (2022-12-01)

A Case of Refractory Myositis
by: Lucas Luk, et al.
Published: (2019-12-01)

Covid-19 in a patient with ANCA-associated systemic vasculitis, receiving anti-B cell therapy (rituximab)
by: T. V. Beketova, et al.
Published: (2020-09-01)

MPO-ANCA-associated necrotizing glomerulonephritis in rheumatoid arthritis; a case report and review of literature
by: Mário Góis, et al.
Published: (2017-04-01)

Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis
by: Shah S, et al.
Published: (2015-08-01)

Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathiesResearch in context
by: Valérie Leclair, et al.
Published: (2023-10-01)

Patient-centred standards of care for adults with myositis
by: James B. Lilleker, et al.
Published: (2017-11-01)